[go: up one dir, main page]

McGuire et al., 1965 - Google Patents

The experimental generation of antibodies to alpha-melanocyte stimulating hormone and adrenocorticotropic hormone.

McGuire et al., 1965

View PDF
Document ID
13771688107861259049
Author
McGuire J
McGill R
Leeman S
Goodfriend T
et al.
Publication year
Publication venue
The Journal of Clinical Investigation

External Links

Snippet

Methods Antigenic compounds were synthesized by conjugating rabbit serum albumin (RSA) with either a-MSH or ACTH by means of the carbodiimide reagent [1-ethyl-3-(3- dimethyl-aminopropyl) carbodiimide], as previously described for bradykinin and other …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48238—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid
    • A61K47/48246—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent
    • A61K47/4833—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being a protein, peptide, polyamino acid drug-peptide, protein or polyamino acid conjugates, i.e. the modifying agent being a protein, peptide, polyamino acid which being linked/complexed to a molecule that being the pharmacologically or therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment

Similar Documents

Publication Publication Date Title
McGuire et al. The experimental generation of antibodies to alpha-melanocyte stimulating hormone and adrenocorticotropic hormone.
Katz et al. Carrier function in anti-hapten immune responses: I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization
Niswender et al. Radioimmunoassay for rat luteinizing hormone with antiovine LH serum and ovine LH-131I
Tashjian Jr et al. Immunochemical identification of parathyroid hormone in non-parathyroid neoplasms associated with hypercalcemia
Weintraub et al. Ectopic production of the isolated beta subunit of human chorionic gonadotropin
Abe et al. Radioimmunoassay of β-MSH in human plasma and tissues
Linsley et al. Detection of larger polypeptides structurally and functionally related to type I transforming growth factor.
KIM et al. Altered immunoreactivity of thyroglobulin in thyroid disease
Siskind et al. Effect of variation in antibody-hapten association constant upon the biologic activity of the antibody
Hahn et al. H‐2‐linked genetic control of antibody response to soluble calf skin collagen in mice
Murray et al. The immunochemical specificity of antisera to bovine parathyroid hormone: an approach to region-specific radioimmunoassay
DK168872B1 (en) Method for producing antibodies for immunological determination of amino-terminal procollagen peptide (type III) and / or procollagen (type III), antibodies produced by the method, use of the antibodies for immunological determination of amino-terminal procollagen peptide (type III) and / or procollagen (type III) and starting product for use in the process
Zimmering et al. Binding of steroids to steroid-specific antibodies
Mizejewski et al. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid
Hopper Comparative Studies on Monotypic IgMλ and IgGκ from an Individual Patient: I. Evidence for Shared VH Idiotypic Determinants
Thorneycroft et al. Preparation and purification of antibodies to steroids
MARTIN et al. The development of a radioimmunoassay for bovine neurophysin
Marchalonis et al. Surface component of primate thymus-derived lymphocytes related to a heavy chain variable region.
Yoshida et al. Genetic Control of the Specificity of Anti-DNP Antibodies: I. Differences in the Specificity of anti-DNP Antibody Produced by Mammalian Species
Ikebuchi et al. An immunological study of a Pb-thionein like protein in rat liver
Wallis et al. Binding specificity of monoclonal antibodies towards the size variants of human growth hormone
Kumar et al. The prevalence of proinsulin-specific antibodies in diabetic patients
Macchia et al. Site-specific anti-c-erb A antibodies recognizing native thyroid hormone receptors: their use to detect the expression and localization of α and β c-erb A proteins in rat liver
Margherita et al. Studies on Thyroglobulin Immunity: VI. Thyroid Hormones and Thyroglobulin Specificity
Motte et al. A two-site immunoradiometric assay for serum calcitonin using monoclonal anti-peptide antibodies